| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5509655 | Clinica Chimica Acta | 2017 | 6 Pages |
Abstract
Virologic, serologic, biochemical responses were achieved in both HBeAg-positive and HBeAg-negative patients under 24-month TDF therapy. Monitoring using baseline HBV DNA and qHBsAg levels would be helpful to predict CVR.
Keywords
HBeAgquantitative hepatitis B surface antigenqHBsAgCHBCVRALTTDFCCCHBV DNAHCCASTAspartate aminotransferaseAlanine aminotransferaseTenofovirtenofovir disoproxil fumarateliver cirrhosisPVRHepatitis B e antigenchronic hepatitis BAntibodyvirologic responseHepatocellular carcinomacovalently closed circular
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Eun-Hyung Yoo, Hyun-Jung Cho,